CPDC Funds Research at CAMH for Developing Alk2-Targeting Pet Tracer for Diagnosis of Pediatric Brain Cancer
HAMILTON, ON and TORONTO, ON, July 6, 2023 – The Centre for Probe Development and Commercialization (CPDC) is pleased to announce a collaboration with Dr. Neil Vasdev at the Centre for Addiction and Mental Health (CAMH) to develop a novel positron emission tomography (PET) tracer specific for the activin receptor-like kinase 2 (ALK2) protein. Under … Read more